The Filtrate (minus Samira) gather to talk about MENTOR the randomized trial of Rituximab versus cyclosporin for the treatment of idiopathic membranous nephropathy.

The Filtrate (minus Matt) gather to talk about SONAR the randomized, placebo-controlled trial of atrasentan for the treatment of diabetic nephropathy.

The Filtrate (minus Samira) gather to talk about predicting the natural (or not so natural history) of IgA nephropathy.

The Filtrate (minus Swapnil) gather to talk about the treatment of hypernatremia.